Background: : The prevalence of fibromyalgia in the general population is reported in numbers that range between 0.5% and 10%, with considerable variability in the populations studied and criteria for diagnosis used. The prevalence in competitive young adult athletes is unknown, but we expect it to be less than the general population.
Objectives: : The objective of this study was to determine the prevalence of fibromyalgia in college student athletes.
Methods: : We conducted a prospective, cross-section cohort evaluation of 641 athletes using the 1990 American College of Rheumatology (ACR) criteria. Volunteer college student athletes were evaluated with a questionnaire and physical examination at preparticipation physical examinations from 1993 to 1999.
Results: : Of the 641 athletes examined, we found only one who met the ACR criteria for a diagnosis of fibromyalgia.
Limitations: : There were a limited number of athletes involved, there was no age- or activity-matched control group, and there were no other demographic information or associated symptoms collected.
Conclusions: : The prevalence for fibromyalgia in this population was found to be 0.16%, which is lower than the prevalence found in studies describing other populations. The protective effects of this population are unclear but could be related to age, fitness level, self-selection, and/or other factors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.rhu.0000147051.71937.42 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Self-Reported Physical Activity Levels in Patients With Arthritis: A Retrospective Study.
Cureus
November 2024
Orthopedics, Jawaharlal Nehru Medical College and Hospital, Bhagalpur, IND.
Introduction Arthritis affects a significant number of adults in the United States, leading to pain and limited mobility. This study explores the impact of physical activity on patients with arthritis, including rheumatoid arthritis, gout, lupus, and fibromyalgia. Using data from the Behavioral Risk Factor Surveillance System (BRFSS), it examines how exercise may improve symptoms and quality of life for these patients.
View Article and Find Full Text PDFDifferent disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years.
RMD Open
December 2024
Rheumatology, Hopital Cochin, Université Paris Descartes Faculté de Médecine, Paris, France.
Introduction: The study aimed to identify and describe disease activity trajectories over 10 years in patients with recent-onset axial spondyloarthritis (axSpA) and determine their impact on long-term outcomes.
Methods: This prospective, multicentre study (Devenir des Spondylarthropathies Indifférenciées Récentes cohort, ClinicalTrials.gov NCT) followed patients with early axSpA for 10 years.
Fibromyalgia comorbidity in Systemic Lupus Erythematosus patients: assessing impact on quality of life.
Adv Rheumatol
December 2024
Department of Internal Medicine, Federal University of Paraiba, João Pessoa, Paraiba, 58050-085, Brazil.
Introduction: The prevalence of Fibromyalgia in patients with Systemic Lupus Erythematosus (SLE) is significantly higher compared to the general population. Despite this frequent association, Fibromyalgia remains underdiagnosed and consequently inadequately treated, negatively affecting the quality of life of these patients.
Objective: This study aims to evaluate the occurrence of Fibromyalgia and its impact on the quality of life of Brazilian patients with SLE treated at a University Hospital in the state of Paraiba.
Metformin and fibromyalgia pathophysiology: current insights and promising future therapeutic strategies.
Mol Biol Rep
December 2024
Department of Physiology, Faculty of Medicine, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Fibromyalgia (FM) is a complex, chronic pain syndrome characterized by widespread musculoskeletal pain, fatigue, and cognitive disturbances. Despite its prevalence, the pathophysiology of FM remains poorly understood, with current treatments often providing limited relief. Recent studies have suggested that metformin, a widely used antidiabetic drug, may have potential therapeutic benefits for chronic pain conditions, including FM.
View Article and Find Full Text PDFMonitoring Addiction to Pregabalin in Northern Algeria by Using Hair Testing.
Electrophoresis
December 2024
Unit of Forensic Medicine, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Pregabalin (PGB) is a novel gamma-aminobutyric acid analog that has been recently approved for the treatment of partial-onset seizures, neuropathic pain, and fibromyalgia. Although PGB presents a low potential for abuse in comparison to other scheduled drugs, the literature reports its potential misuse, especially among individuals with former or current drug addiction. The present study aimed to develop and validate a novel method for the determination of PGB in hair to perform a retrospective observational study on the misuse of this drug in a population of addicted subjects from Northern Algeria.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!